{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:22:34Z","timestamp":1765380154843},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00393-017-0360-y","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T07:28:43Z","timestamp":1502782123000},"page":"664-672","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Uveitis bei juveniler idiopathischer Arthritis"],"prefix":"10.1007","volume":"76","author":[{"given":"I.","family":"Foeldvari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Walscheid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heiligenhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,15]]},"reference":[{"key":"360_CR1","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00296-013-2696-1","volume":"33","author":"G Amarilyo","year":"2013","unstructured":"Amarilyo G, Rullo OJ, Mccurdy DK et al (2013) Folate usage in MTX-treated juvenile idiopathic arthritis (JIA) patients is inconsistent and highly variable. Rheumatol Int 33:2437\u20132440","journal-title":"Rheumatol. Int."},{"key":"360_CR2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11926-011-0229-z","volume":"14","author":"S Angeles-Han","year":"2012","unstructured":"Angeles-Han S, Yeh S (2012) Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitis. Curr Rheumatol Rep 14:142\u2013149","journal-title":"Curr Rheumatol Rep"},{"key":"360_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2016.09.018","volume":"173","author":"MR Bohm","year":"2017","unstructured":"Bohm MR, Tappeiner C, Breitbach MA et al (2017) Ocular hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Am J Ophthalmol 173:45\u201355","journal-title":"Am J Ophthalmol"},{"key":"360_CR4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","volume":"35","author":"R Bou","year":"2015","unstructured":"Bou R, Adan A, Borras F et\u00a0al (2015) Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int 35:777\u2013785","journal-title":"Rheumatol. Int."},{"key":"360_CR5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/09273948.2013.871566","volume":"23","author":"J Boer De","year":"2015","unstructured":"De Boer J, Steijaert A, Van Den Bor R et\u00a0al (2015) Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopathic arthritis. Ocul Immunol Inflamm 23:67\u201373","journal-title":"Ocul. Immunol. Inflamm."},{"key":"360_CR6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/rheumatology\/kev279","volume":"54","author":"A Felis-Giemza","year":"2015","unstructured":"Felis-Giemza A, Moots RJ (2015) Measurement of anti-drug antibodies to biologic drugs. Rheumatology (Oxford) 54:1941\u20131943","journal-title":"Rheumatology (Oxford)"},{"key":"360_CR7","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/acr.22613","volume":"67","author":"I Foeldvari","year":"2015","unstructured":"Foeldvari I, Becker I, Horneff G (2015) Uveitis events during Adalimumab, Etanercept, and Methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry. Arthritis Care Res 67:1529\u20131535","journal-title":"Arthritis Care Res"},{"key":"360_CR8","first-page":"362","volume":"32","author":"I Foeldvari","year":"2005","unstructured":"Foeldvari I, Wierk A (2005) Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J\u00a0Rheumatol 32:362\u2013365","journal-title":"J. Rheumatol."},{"key":"360_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","volume":"120","author":"AC Gregory 2nd","year":"2013","unstructured":"Gregory AC 2nd, Kempen JH, Daniel E et\u00a0al (2013) Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology 120:186\u2013192","journal-title":"Ophthalmology"},{"key":"360_CR10","doi-asserted-by":"crossref","first-page":"e0164312","DOI":"10.1371\/journal.pone.0164312","volume":"11","author":"AJ Haasnoot","year":"2016","unstructured":"Haasnoot AJ, Vernie LA, Rothova A et\u00a0al (2016) Impact of juvenile idiopathic arthritis associated uveitis in early adulthood. PLOS ONE 11:e0164312","journal-title":"PLOS ONE"},{"key":"360_CR11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/acr.21674","volume":"64","author":"A Heiligenhaus","year":"2012","unstructured":"Heiligenhaus A, Foeldvari I, Edelsten C et al (2012) Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a\u00a0consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res 64:1365\u20131372","journal-title":"Arthritis Care Res"},{"key":"360_CR12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/09273948.2013.791701","volume":"21","author":"A Heiligenhaus","year":"2013","unstructured":"Heiligenhaus A, Heinz C, Edelsten C et\u00a0al (2013) Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 21:180\u2013191","journal-title":"Ocul. Immunol. Inflamm."},{"key":"360_CR13","first-page":"92","volume":"112","author":"A Heiligenhaus","year":"2015","unstructured":"Heiligenhaus A, Minden K, Foll D et\u00a0al (2015) Uveitis in juvenile idiopathic arthritis. Dtsch Arztebl Int 112:92\u2013100","journal-title":"Dtsch Arztebl Int"},{"key":"360_CR14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Niewerth M, Ganser G et al (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a\u00a0population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 46:1015\u20131019","journal-title":"Rheumatology"},{"key":"360_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00347-016-0262-4","volume":"113","author":"A Heiligenhaus","year":"2016","unstructured":"Heiligenhaus A, Tappeiner C, Walscheid K et\u00a0al (2016) Uveitis associated with juvenile idiopathic arthritis: optimization of immunomodulatory therapy. Ophthalmologe 113:391\u2013397","journal-title":"Ophthalmologe"},{"key":"360_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00347-008-1742-y","volume":"105","author":"C Heinz","year":"2008","unstructured":"Heinz C, Pleyer U, Ruokonnen P et\u00a0al (2008) Sekund\u00e4rglaukom bei Kindern mit Uveitis. Ophthalmologe 105:438\u2013444","journal-title":"Ophthalmologe"},{"key":"360_CR17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"360_CR18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/ard.2004.026955","volume":"64","author":"K Kotaniemi","year":"2005","unstructured":"Kotaniemi K, Arkela-Kautiainen M, Haapasaari J et al (2005) Uveitis in young adults with juvenile idiopathic arthritis: a\u00a0clinical evaluation of 123 patients. Ann Rheum Dis 64:871\u2013874","journal-title":"Ann. Rheum. Dis."},{"key":"360_CR19","first-page":"143","volume":"32","author":"K Kotaniemi","year":"2014","unstructured":"Kotaniemi K, Sihto-Kauppi K, Salomaa P et al (2014) The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4\u2011year cohorts from 1990\u20131993 and 2000\u20132003. Clin Exp Rheumatol 32:143\u2013147","journal-title":"Clin Exp Rheumatol"},{"key":"360_CR20","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/annrheumdis-2012-201544","volume":"71","author":"CL Krieckaert","year":"2012","unstructured":"Krieckaert CL, Nurmohamed MT, Wolbink GJ (2012) Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a\u00a0dose dependent manner. Ann Rheum Dis 71:1914\u20131915","journal-title":"Ann. Rheum. Dis."},{"key":"360_CR21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","volume":"100","author":"E Miserocchi","year":"2016","unstructured":"Miserocchi E, Modorati G, Berchicci L et al (2016) Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol 100:782\u2013786","journal-title":"Br J Ophthalmol"},{"key":"360_CR22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan AV, Dick AD, Jones AP et\u00a0al (2017) Adalimumab plus Methotrexate for uveitis in juvenile idiopathic arthritis. N\u00a0Engl J Med 376:1637\u20131646","journal-title":"N Engl J Med"},{"key":"360_CR23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acr.22214","volume":"66","author":"G Simonini","year":"2014","unstructured":"Simonini G, Druce K, Cimaz R et al (2014) Current evidence of anti-tumor necrosis factor alpha treatment efficacy in childhood chronic uveitis: a\u00a0systematic review and meta-analysis approach of individual drugs. Arthritis Care Res 66:1073\u20131084","journal-title":"Arthritis Care Res"},{"key":"360_CR24","first-page":"936","volume":"33","author":"C Tappeiner","year":"2015","unstructured":"Tappeiner C, Klotsche J, Schenck S et al (2015) Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a\u00a0cross-sectional analysis of a\u00a0prospective nationwide study. Clin Exp Rheumatol 33:936\u2013944","journal-title":"Clin Exp Rheumatol"},{"key":"360_CR25","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3899\/jrheum.160231","volume":"43","author":"C Tappeiner","year":"2016","unstructured":"Tappeiner C, Mesquida M, Adan A et\u00a0al (2016) Evidence for Tocilizumab as a\u00a0treatment option in refractory uveitis associated with juvenile idiopathic arthritis. J\u00a0Rheumatol 43:2183\u20132188","journal-title":"J. Rheumatol."},{"key":"360_CR26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.140410","volume":"42","author":"C Tappeiner","year":"2015","unstructured":"Tappeiner C, Miserocchi E, Bodaghi B et\u00a0al (2015) Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis. J\u00a0Rheumatol 42:706\u2013711","journal-title":"J. Rheumatol."},{"key":"360_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/acr.22649","volume":"68","author":"C Tappeiner","year":"2016","unstructured":"Tappeiner C, Schenck S, Niewerth M et\u00a0al (2016) Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a\u00a0nationwide pediatric rheumatology database. Arthritis Care Res 68:46\u201354","journal-title":"Arthritis Care Res"},{"key":"360_CR28","first-page":"148","volume":"34","author":"EH Dijkhuizen Van","year":"2016","unstructured":"Van Dijkhuizen EH, Pouw JN, Scheuern A et al (2016) Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a\u00a0cross-sectional, observational study. Clin Exp Rheumatol 34:148\u2013154","journal-title":"Clin Exp Rheumatol"},{"key":"360_CR29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12969-016-0126-0","volume":"14","author":"S Verazza","year":"2016","unstructured":"Verazza S, Davi S, Consolaro A et\u00a0al (2016) Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept. Pediatr Rheumatol Online J 14:68","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"360_CR30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3899\/jrheum.120583","volume":"40","author":"ME Zannin","year":"2013","unstructured":"Zannin ME, Birolo C, Gerloni VM et al (2013) Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1\u2011year followup data from the Italian Registry. J Rheumatol 40:74\u201379","journal-title":"J. Rheumatol."}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-017-0360-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T08:37:36Z","timestamp":1506933456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-017-0360-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s00393-017-0360-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,15]]}}}